Autopsy report · NCT02452710

Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors

“Study funding was completed.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 1 year 6 months before it stopped.
• 40 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Dana-Farber Cancer Institute

Sponsor type

University, hospital or other

Conditions

Fatigue in Cancer Survivors

Interventions

Placebo

Participants

40

Sites

1

Countries

United States

Trials that died the same way

• Abuse Potential of Buprenorphine/Naloxone
  “Funding ended for the study” (82% match in meaning)
• Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
  “Funding completed.” (78% match in meaning)
• Changes in Bone Turnover With Increased Incretin Hormone Exposure
  “Study closed by sponsor. Funding ended.” (77% match in meaning)
• Managing Chronic Tendon Pain by Metformin
  “The study funding has ended.” (76% match in meaning)
• Augmented Reality-based Telerehabilitation Platform for Patients With Stroke
  “Study did not receive funding” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.